MYLIN TORRES was named director of the Glenn Family Breast Center at Winship Cancer Institute of Emory University. She succeeds Ruth O’Regan, who now heads the University of Wisconsin Division of Hematology and Oncology. Torres is an associate professor in Emory’s Department of Radiation Oncology and a member of Winship’s Cancer Prevention and Control Program....
In a unanimous vote, the FDA Oncologic Drugs Advisory Committee advised the agency to accept the metric of “minimal residual disease,” or MRD, as a basis for accelerated approvals of therapies in all settings of multiple myeloma.
